Suchen
Medtronic PLC
MDTZur Watchlist hinzufügen
82.350USD
-0.940-1.13%
Handelsschluss 07/21, 16:00（ET）Kurse um 15 Minuten verzögert
105.69BMarktkapitalisierung
22.89KGV TTM
mehr Informationen über Medtronic PLC Unternehmen
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Medtronic PLC Informationen
BörsenkürzelMDT
Name des UnternehmensMedtronic PLC
IPO-datumNov 21, 1977
CEOMartha (Geoffrey S)
Anzahl der mitarbeiter95000
WertpapierartOrdinary Share
GeschäftsjahresendeNov 21
AddresseBuilding Two Parkmore Business Park West
StadtDUBLIN
BörseNASDAQ OMX NASDAQ Basic NYSE
LandIreland
PostleitzahlH91 4K49
Telefon1135314381700
Websitehttps://www.medtronic.com/
BörsenkürzelMDT
IPO-datumNov 21, 1977
CEOMartha (Geoffrey S)
Führungskräfte von Medtronic PLC
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
23.61K
+8.06%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
19.54K
+9.74%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
10.10K
+18.86%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Independent Director
Independent Director
7.63K
+24.97%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Medtronic PLC?
Die fünf größten Anteilseigner von Medtronic PLC sind: Mr. Geoffrey S. (Geoff) Martha
Wie viele Institutionen halten Anteile an Medtronic PLC (MDT)?
Mit Stand vom 2026Q1 halten 3854 Institutionen Anteile an Medtronic PLC, mit einem Gesamtmarktwert von etwa 1.12B, was 86.90% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -35115160.00 gestiegen.
Was ist die größte Einnahmequelle von Medtronic PLC?
Am 2026Q1 erzielte das Geschäft mit Cardiac Rhythm & Heart Failure für Medtronic PLC den höchsten Umsatz in Höhe von 1.86B, was 20.58% des Gesamtumsatzes entspricht.